Dosing in pediatric patients is generally extrapolated from adult dosing guidelines, but adjustments are often made based on body surface area (BSA). Clinical trials and studies are ongoing to determine the optimal dosing strategies for pediatric patients. The dosing regimen typically involves intravenous administration over several days, with cycles repeated every few weeks.
